4.26
price down icon0.47%   -0.02
after-market Handel nachbörslich: 4.14 -0.12 -2.82%
loading

Radiopharm Theranostics Ltd Adr Aktie (RADX) Neueste Nachrichten

pulisher
Dec 04, 2025

Radiopharm Theranostics Announces Successful General Meeting Resolutions - TipRanks

Dec 04, 2025
pulisher
Nov 28, 2025

B. Riley Lowers Radiopharm Theranostics (NASDAQ:RADX) Price Target to $13.00 - Defense World

Nov 28, 2025
pulisher
Nov 26, 2025

Form 6-KReport of foreign issuer [Rules 13a-16 and 15d-16] - ADVFN

Nov 26, 2025
pulisher
Nov 18, 2025

Radiopharm Theranostics Receives Approval to Initiate Phase 1 Therapeutic Trial of RAD 402 (KLK3-mAb with Tb161) in Advanced Prostate Cancer - Sahm

Nov 18, 2025
pulisher
Nov 17, 2025

Radiopharm Theranostics Announces 50% Enrollment in Phase 2b Clinical Trial of RAD101 Imaging in Brain Metastases - Sahm

Nov 17, 2025
pulisher
Nov 16, 2025

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Intellia Therapeutics (NTLA) and Acrivon Therapeutics, Inc. (ACRV) - The Globe and Mail

Nov 16, 2025
pulisher
Nov 15, 2025

Analysts’ Top Healthcare Picks: Serina Therapeutics (SER), Cybin (CYBN) - The Globe and Mail

Nov 15, 2025
pulisher
Nov 12, 2025

Analysts Are Bullish on These Healthcare Stocks: Beyond Air (XAIR), Diamedica Therapeutics (DMAC) - The Globe and Mail

Nov 12, 2025
pulisher
Nov 05, 2025

Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing - The Globe and Mail

Nov 05, 2025
pulisher
Nov 05, 2025

Radiopharm Theranostics Announces Extraordinary General Meeting for Shareholder Resolutions - MSN

Nov 05, 2025
pulisher
Nov 03, 2025

Radiopharm Theranostics Limited: Promising Financial and Clinical Outlook Justifies Buy Rating - TipRanks

Nov 03, 2025
pulisher
Nov 03, 2025

Radiopharm (ASX:RAD, Nasdaq:RADX) to Showcase Oncology Pipeline at Deutsche Bank ADR Conference - Kalkine Media

Nov 03, 2025
pulisher
Nov 02, 2025

Radiopharm Theranostics to Present at Deutsche Bank ADR Virtual Investor Conference - TipRanks

Nov 02, 2025
pulisher
Oct 31, 2025

Analysts Are Bullish on These Healthcare Stocks: Bioxcel Therapeutics (BTAI), Perspective Therapeutics (CATX) - The Globe and Mail

Oct 31, 2025
pulisher
Oct 31, 2025

CORRECTION -- International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 04, 2025 - The Globe and Mail

Oct 31, 2025
pulisher
Oct 31, 2025

International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 04, 2025 - The Manila Times

Oct 31, 2025
pulisher
Oct 30, 2025

International companies to host live webcasts at Deutsche - GlobeNewswire

Oct 30, 2025
pulisher
Oct 24, 2025

Radiopharm Theranostics Announces November AGM with Key Resolutions - MSN

Oct 24, 2025
pulisher
Oct 21, 2025

Radiopharm Theranostics secures A$35 million in private placement - Investing.com India

Oct 21, 2025
pulisher
Oct 18, 2025

Analysts Are Bullish on Top Healthcare Stocks: Abbott Laboratories (ABT), Achieve Life Sciences (ACHV) - The Globe and Mail

Oct 18, 2025
pulisher
Oct 12, 2025

Radiopharm Theranostics Accelerates RAD202 Clinical Trial Following Positive Safety Review - MSN

Oct 12, 2025
pulisher
Oct 09, 2025

MasterCraft Boat Holdings Inc (MCFT): What the Financials Tell Us - fostersleader.com

Oct 09, 2025
pulisher
Oct 09, 2025

Is Buying Stock In Radiopharm Theranostics Ltd ADR (RADX) A Good Move Today? - fostersleader.com

Oct 09, 2025
pulisher
Oct 09, 2025

Major Brokerage Firms Issue Research Notes on Surgepays Inc (SURG) - fostersleader.com

Oct 09, 2025
pulisher
Oct 01, 2025

Radiopharm Theranostics Limited: Strategic Advancements and Financial Stability Support Buy Rating - TipRanks

Oct 01, 2025
pulisher
Aug 29, 2025

Analysts Offer Insights on Healthcare Companies: Acrivon Therapeutics, Inc. (ACRV) and Jazz Pharmaceuticals (JAZZ) - The Globe and Mail

Aug 29, 2025
pulisher
Aug 22, 2025

Radiopharm Theranostics Hosts Webinar Series on Radiopharmaceutical Therapies - MSN

Aug 22, 2025
pulisher
Jul 30, 2025

Radiopharm Theranostics: Promising Pipeline and Strategic Advancements Drive Buy Rating - TipRanks

Jul 30, 2025
pulisher
Jul 29, 2025

Radiopharm Theranostics Limited: Promising Clinical Developments and Strategic Growth Potential Drive Buy Rating - TipRanks

Jul 29, 2025
pulisher
Jul 28, 2025

FDA clears Radiopharm’s IND application for Lu177-B7H3 antibody By Investing.com - Investing.com India

Jul 28, 2025
pulisher
Jul 28, 2025

FDA clears Radiopharm’s IND application for Lu177-B7H3 antibody - Investing.com

Jul 28, 2025
pulisher
Jul 28, 2025

Radiopharm Theranostics receives FDA IND approval for Betabart (RV-01) By Investing.com - Investing.com India

Jul 28, 2025
pulisher
Jul 28, 2025

Radiopharm Theranostics receives FDA IND approval for Betabart (RV-01) - Investing.com

Jul 28, 2025
pulisher
Jul 28, 2025

Radiopharm Theranostics Receives FDA Investigational New Drug Clearance for RV-01 Cancer Therapy - new.smallcaps.com.au

Jul 28, 2025
pulisher
Jul 22, 2025

Dr Oliver Sartor Appointed to Radiopharm Scientific Advisory Board - GlobeNewswire Inc.

Jul 22, 2025
pulisher
Jul 22, 2025

Radiopharm Theranostics adds Dr Oliver Sartor to scientific advisory board By Investing.com - Investing.com India

Jul 22, 2025
pulisher
Jul 22, 2025

Radiopharm Theranostics adds Dr Oliver Sartor to scientific advisory board - Investing.com

Jul 22, 2025
pulisher
Jul 22, 2025

Radiopharm Theranostics (NASDAQ:RADX) Now Covered by Brookline Capital Management - Defense World

Jul 22, 2025
pulisher
Jul 21, 2025

Radiopharm Theranostics stock initiated with Buy rating at Brookline Capital - Investing.com

Jul 21, 2025
pulisher
Jul 21, 2025

Radiopharm Theranostics stock initiated with Buy rating at Brookline Capital By Investing.com - Investing.com India

Jul 21, 2025
pulisher
Jul 16, 2025

Radiopharm Theranostics receives $4.5 million R&D tax incentive - Investing.com India

Jul 16, 2025
pulisher
Jul 16, 2025

Radiopharm Theranostics receives $4.5 million R&D tax incentive By Investing.com - Investing.com South Africa

Jul 16, 2025
$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
Kapitalisierung:     |  Volumen (24h):